Precigen, INC Form 4 insider transactions

Rutul R Shah, Chief Operating Officer of Precigen, Inc., sold 32,739 shares of common stock on August 6, 2026 for $6.86 per share.

Rutul R Shah, Chief Operating Officer of Precigen, Inc., sold 33,772 shares of common stock on August 3, 2026 for $6.50 per share.

Harry Thomasian Jr., Chief Financial Officer of Precigen, Inc., sold 100,000 shares of common stock on July 31, 2026 for $6.06 per share.

Precigen, Inc. CFO Harry Thomasian Jr. reported the sale of company stock under a pre-arranged trading plan.

Precigen, Inc. Chief Operating Officer Rutul R. Shah reported the sale of 42,924 shares of common stock under a pre-arranged 10b5-1 trading plan.

Precigen, Inc. (PGEN) President and CEO Helen Sabzevari sold 346,836 shares of common stock under a pre-arranged 10b5-1 trading plan.

Precigen, Inc. reports that Chief Financial Officer Harry Thomasian Jr. sold 41,884 shares of common stock to cover tax obligations upon the vesting of restricted stock units.

Precigen's Chief Commercial Officer, Phil Tennant, sold 30,272 shares of common stock to cover tax obligations upon the vesting of restricted stock units.

Precigen's Chief Operating Officer, Rutul R. Shah, sold 42,703 shares of common stock to cover tax obligations upon the vesting of restricted stock units.

Donald P. Lehr, Chief Legal Officer of Precigen, Inc., reported the sale of 29,131 shares of common stock to cover tax withholding obligations upon the vesting of restricted stock units.

Precigen's President and CEO, Helen Sabzevari, sold 119,250 shares of common stock to cover tax obligations upon the vesting of restricted stock units.

Precigen CFO Harry Thomasian Jr. acquired 87,500 shares of common stock through the vesting of restricted stock units.

Chief Commercial Officer Phil Tennant acquired 62,500 shares of Precigen common stock through the vesting of restricted stock units.

Precigen Chief Operating Officer Rutul R. Shah acquired 90,000 shares of common stock through the vesting of restricted stock units.

Precigen President and CEO Helen Sabzevari acquired 250,000 shares of common stock following the vesting of restricted stock units.

Chief Legal Officer Donald P. Lehr acquired 62,500 shares of Precigen common stock through the vesting of restricted stock units.

Precigen Chief Legal Officer Donald P. Lehr was granted 358,000 stock options and 107,000 restricted stock units.

Precigen CEO Helen Sabzevari was granted 1,366,000 stock options and 410,000 restricted stock units on April 20, 2026.

Precigen COO Rutul R. Shah was granted 395,000 stock options and 118,000 restricted stock units on April 20, 2026.

Precigen Chief Commercial Officer Phil Tennant was granted 385,000 stock options and 115,000 restricted stock units on April 20, 2026.

Precigen CFO Harry Thomasian Jr. was granted 399,000 stock options and 120,000 restricted stock units on April 20, 2026.

Randal J. Kirk, a Director and 10% owner of Precigen, Inc., reported the sale of over 4.7 million shares of common stock for approximately $15.7 million.

Precigen's Chief Financial Officer, Harry Thomasian Jr., acquired 40,293 shares of common stock through the vesting and conversion of restricted stock units.

Precigen's Chief Commercial Officer, Phil Tennant, converted 42,110 Restricted Stock Units into common stock, increasing his direct beneficial ownership.

Precigen's President and CEO, Helen Sabzevari, acquired 321,100 shares of common stock through the vesting of restricted stock units.

Precigen's Chief Operating Officer, Rutul R. Shah, acquired and converted 44,495 restricted stock units into common stock.

Precigen's Chief Legal Officer, Donald P. Lehr, increased his direct beneficial ownership of common stock by 40,443 shares following the vesting and conversion of Restricted Stock Units.

Randal J. Kirk, a Director and 10% owner of Precigen, Inc., acquired 143,678 shares of common stock through the vesting of restricted stock units.

Precigen Director Nancy H. Agee converted 71,839 Restricted Stock Units into common stock following their vesting on March 13, 2026.

Precigen Director Cesar L. Alvarez converted 71,839 Restricted Stock Units into common stock on March 13, 2026, increasing his direct beneficial ownership.